Aprea Therapeutics, Inc.

APRENASDAQ Global Select·USD·Closed

APRENASDAQ·USD·Closed

$0.75

+2.22%

$0.75

+$0.02 (2.22%)

52W Range

12thpctl

Volume

0.21×avg

Mkt Cap

4.90MUSD

P/E

-0.5TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

12thpctl

Volume

0.21×avg

Market Cap

4.90MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-10649.9%

ROIC-29.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio8.92×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required